The Cancer Pharmacology Lab was under the spotlight at the Annual Meeting of the Pharmacology & Molecular Mechanisms Group (PAMM) of r the European Organization for Cancer Research (EORTC), in Antwerp, Belgium, February 2016
The abstracts “Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cells” by Dr. Leticia G. Leon and “Spliceosome inhibition as novel strategy against diffuse malignant peritoneal mesothelioma” by Rocco Sciarrillo were selected as oral presentations, and during the closing ceremony they both received the young investigator award as best oral presentations.
The success of Dr. Leon, as well as her recent iCARE Marie Curie grant to work in the Cancer Pharmacology Lab, have been also described in a Press release of the University of Pisa
Press release: www.ao-pisa.toscana.it
Pdf: Synergistic activity of the c-Met and tubulin inhibitor tivantinib
Dr. Elisa Giovannetti, who worked in the Scientific Committee in collaboration with the main local organizer of this extremely interesting pharmacological meeting, Prof. Christian Rolfo, had an invited lecture on “Resistance mechanisms in new drugs and how to overcome it. The point of view of the pharmacologist”
Pdf: Resistance mechanisms in new drugs and how to overcome it